Michigan Split-belt Treadmill Training Program to Improve Acute Knee Biomechanics After ACL Reconstruction
Launched by UNIVERSITY OF MICHIGAN · Jul 26, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a special treadmill training program to help improve how the knee moves after surgery for an ACL injury. The main focus is to see if walking on a treadmill that moves at different speeds for each leg (called split-belt walking) helps the knee recover better than walking on a treadmill where both legs move at the same speed (tied-belt walking). Researchers want to find out if there are different effects on knee movement depending on when during the walking cycle the training happens.
To take part in this study, people need to be between 14 and 45 years old and have had a complete ACL tear that was fixed with surgery using their own tissue within the last 10 months. Participants will need to be able to speak English and agree to follow the study’s guidelines. If a person has had previous knee injuries or surgeries, is pregnant, or has certain complications, they may not be eligible. Those who qualify can expect to participate in a 20-minute treadmill session and help researchers learn more about improving knee recovery after ACL surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged 14-45 years
- • suffered an acute, complete ACL rupture as confirmed by MRI and physical exam
- • have undergone ACL reconstruction w autograft within the past 10 months
- • willingness to participate in testing and follow-up as outlined in the protocol
- • English-speaking
- Exclusion Criteria:
- • inability to provide written informed consent
- • female subjects who are pregnant or are planning to become pregnant (self-reported)
- • previous ACL injury
- • previous surgery to either knee
- • bony fracture accompanying ACL injury
- • patients who experienced a knee dislocation
- • patients who had their ACL reconstructed with an allograft
- • patients who underwent a multi-ligamentous and/or staged ACL reconstruction
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Riann M Palmieri-Smith, PhD, ATC
Principal Investigator
University of Michigan
Chandramouli Krishnan, PT, PhD
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported